BeiGene, Ltd. (6160.HK)

HKD 105.9

(-1.4%)

Inventory Summary of BeiGene, Ltd.

BeiGene, Ltd.'s latest annual inventory in 2023 was 416.12 Million USD , up 47.38% from previous year.
BeiGene, Ltd.'s latest quarterly inventory in 2024 Q2 was 443.26 Million USD , down -0.91% from previous quarter.
BeiGene, Ltd. reported annual inventory of 282.34 Million USD in 2022, up 16.37% from previous year.
BeiGene, Ltd. reported annual inventory of 242.62 Million USD in 2021, up 171.72% from previous year.
BeiGene, Ltd. reported quarterly inventory of 447.34 Million USD for 2024 Q1, up 7.5% from previous quarter.
BeiGene, Ltd. reported quarterly inventory of 416.12 Million USD for 2023 Q4, up 31.3% from previous quarter.

Annual Inventory Chart of BeiGene, Ltd. (2023 - 2013)

Historical Annual Inventory of BeiGene, Ltd. (2023 - 2013)

Year	Inventory	Inventory Growth
2023	416.12 Million USD	47.38%
2022	282.34 Million USD	16.37%
2021	242.62 Million USD	171.72%
2020	89.29 Million USD	212.73%
2019	28.55 Million USD	75.8%
2018	16.24 Million USD	48.6%
2017	10.93 Million USD	0.0%
2016	- USD	0.0%
2015	- USD	0.0%
2014	- USD	0.0%
2013	- USD	0.0%

Year	Inventory	Inventory Growth
2024 Q2	443.26 Million USD	-0.91%
2024 Q1	447.34 Million USD	7.5%
2023 Q4	416.12 Million USD	31.3%
2023 Q1	296.99 Million USD	5.19%
2023 Q3	316.92 Million USD	-1.37%
2023 FY	416.12 Million USD	47.38%
2023 Q2	321.33 Million USD	8.19%
2022 Q4	282.34 Million USD	-2.94%
2022 Q3	290.91 Million USD	10.95%
2022 FY	282.34 Million USD	16.37%
2022 Q2	262.21 Million USD	6.75%
2022 Q1	245.62 Million USD	1.24%
2021 Q3	150.97 Million USD	28.4%
2021 Q1	72.97 Million USD	-18.28%
2021 Q4	242.62 Million USD	60.7%
2021 Q2	117.58 Million USD	61.14%
2021 FY	242.62 Million USD	171.72%
2020 Q1	28.77 Million USD	0.78%
2020 Q2	33.23 Million USD	15.5%
2020 Q4	89.29 Million USD	151.35%
2020 FY	89.29 Million USD	212.73%
2020 Q3	35.52 Million USD	6.89%
2019 Q4	28.55 Million USD	-23.88%
2019 FY	28.55 Million USD	75.8%
2019 Q2	49.04 Million USD	273.27%
2019 Q3	37.51 Million USD	-23.52%
2019 Q1	13.14 Million USD	-19.1%
2018 Q2	6.32 Million USD	-15.68%
2018 FY	16.24 Million USD	48.6%
2018 Q3	19.69 Million USD	211.59%
2018 Q4	16.24 Million USD	-17.55%
2018 Q1	7.49 Million USD	-31.4%
2017 FY	10.93 Million USD	0.0%
2017 Q4	10.93 Million USD	91.35%
2017 Q3	5.71 Million USD	0.0%
2017 Q1	- USD	0.0%
2017 Q2	- USD	0.0%
2016 Q2	- USD	0.0%
2016 Q4	- USD	0.0%
2016 Q3	- USD	0.0%
2016 Q1	- USD	0.0%
2016 FY	- USD	0.0%
2015 Q1	- USD	0.0%
2015 Q3	- USD	0.0%
2015 Q4	- USD	0.0%
2015 FY	- USD	0.0%
2015 Q2	- USD	0.0%
2014 Q4	- USD	0.0%
2014 FY	- USD	0.0%
2013 FY	- USD	0.0%

Peer Inventory Comparison of BeiGene, Ltd.

Name	Inventory	Inventory Difference
Uni-Bio Science Group Limited	36.39 Million HKD	-1043.444%
CK Life Sciences Int'l., (Holdings) Inc.	1.2 Billion HKD	65.454%